
Pension fund managers need their wits about them if they head into private equity
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.
I was programmed early in life to regard all gambling establishments as dens of wolves, which rather reduces my enjoyment of spending time in them.
Nevertheless, one night, many decades ago, I found myself in a Stakis casino in Edinburgh — in those days, stockbrokers went where their clients wanted to go, especially after dinner. To make things more weird, my client, who ran a large life and pension fund, assured me he had a system which could beat the house at roulette. Even in my highly relaxed state, I then knew that things might well go from weird to bonkers.
I was looking for a route out, so sat at a blackjack table. The croupier removed me for being too drunk after I tried to take the irrational step of splitting two tens into separate hands. It was an act of kindness from Stakis that I will not forget. I left my client to his probability defying quest.
I've been thinking about that evening since hearing the government has forcefully persuaded pension funds to invest in private equity. Seventeen have signed what is called the Mansion House accord, promising to put at least 10 per cent of the defined contribution default funds into PE vehicles, half of them in the UK, investing £25bn.
Various questions arise.
First, why is this allocation only being made for default funds? Some might suggest that these funds are the ones where the beneficiaries have no say in how their money is invested. Presumably, if these investment companies thought that private equity was a great place to invest, they would have had this allocation anyway. So what has changed? If they are now raising their PE allocation, will they explain to the beneficiaries how this is in their interest, especially as fees on this allocation are likely to be a multiple of those on other investments, such as tracker funds and bonds? Read More Asking prices for UK homes suffer sharpest August drop since 2018
Second, why is only half of the PE allocated to the UK? And who will keep an eye on whether the UK allocation actually ends up invested in the UK? Say a fund buys units in a UK-based PE fund. That fund might invest outside the UK, or in UK-incorporated companies which then invest in their overseas plants, or UK companies which receive the extra funds and leave them in their bank account.
'Investing in the UK' is a good intention, but the practicalities are complex. The same issue might well arise trying to get Isa investors to 'invest in the UK'. That is clear comparing two large UK-listed stocks. Tesco is a company mainly operating in the UK but Rio, the mining company, does very little mining here. Both are 'British' companies. Would we want investment rules to differentiate between the two?
Private equity funds not only have higher fees than many other funds but also generally do not allow investors to sell their holdings at short notice. When the investment sun is shining, this lack of liquidity can seem a minor issue, but when markets become volatile major issues can arise. Say you allocate 10 per cent to private equity, 20 per cent to bonds and 70 per cent to equities then a 2008-type market comes along and your equities halve. Your PE allocation has then risen to 15 per cent. Also, if there are any redemptions in the fund you can only sell the bonds and equities as the PE fund is closed, making this unbalancing worse.
What's wrong with these funds investing more in listed UK equities? After all, there are many who think UK equities look modestly valued by international standards. When investing in listed shares, I believe that I am on a fairly level playing field against other potential shareholders. We have roughly the same information, but may analyse it differently, leading one to buy and another to sell.
In my experience, investing in private equity is like entering that Edinburgh casino — it can feel like entering a wolf den. The bankers who ask you to fund the company have much more information that you, the investor, and the management team may have angles about which neither banker nor investor are aware. You meet intensively for a period to arrange the private finance of a business and then are joined at the hip, unable to sell for many years after. I'll stick with listed stocks myself.
Lastly, the expression goes 'the road to hell is paved with good intentions'. Unfortunately, government actions often have unintended consequences. Announcing a compact which requires a large number of funds to buy into a limited PE market creates two unintended risks. The first is that anyone with any junk to sell will dress it up as a UK PE deal, expecting hungry buyers. The second is that existing PE investors will find this wave of cash drives down current investment returns, leading them to invest less in the UK.
Any move to mandate funds to invest in the UK — the so-called Treasury backstop — is likely to scare off more funds than it is able to corral. Even suggesting such a mandate shows that important people lack understanding of how markets work. This is a classic example of how the unintended consequences of government actions often outweigh the action itself, whatever the 'good intentions'.
Simon Edelsten is a fund manager at Goshawk Asset Management
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Axios
28 minutes ago
- Axios
Developer pulls plans for Heritage Square rezoning in Durham
A Chicago developer proposing a new life sciences campus near downtown Durham has pulled its rezoning application from the City Council at the 11th hour. Why it matters: The plans from Chicago-based Sterling Bay envisioned a mixed-use life sciences campus on the site of the Heritage Square shopping center on the edge of the Hayti neighborhood and across the Durham Freeway from downtown. The shopping center currently sits vacant, but was once home to a grocery store, some smaller shops and restaurants. Driving the news: The developer's plans, which were set to be heard at Monday night's Durham City Council meeting, were facing pushback from residents of Hayti, a historically Black neighborhood that has faced rising costs in recent years. Many of those residents expressed concern at the City Council meeting that a project of that size will cause property valuations across the neighborhood to soar even more, the News & Observer reported. Before the council could vote, however, Sterling Bay withdrew its application, a move that surprised the council and the dozens of people in the audience. The council ultimately voted to approve the withdrawal 5-2. Zoom in: A Sterling Bay spokesperson told Axios the company is disappointed that the project will not proceed, and noted that it's worked for the past three years to speak with residents in the neighborhood about the project. The company said it proposed $2.3 million in contributions to the local community as part of its rezoning, including scholarship money for N.C. Central University and Durham Technical Community College, a contribution to the Hayti Promise Community Development Corporation, affordable retail space and several other measures. "While the initiative will not move forward, we remain proud of the collaborative efforts that shaped it," the spokesperson said in a statement. What's next: The withdrawal means that Sterling Bay could resubmit another rezoning in six months or potentially build without it. Sterling Bay only filed the rezoning after discovering issues with the bedrock that made building underground parking more expensive and required taller buildings. The company had bought the 10-acre property for $62 million in 2022, according to county records. Sterling Bay said it was "exploring new steps" but declined to comment further on what might become of the property. Between the lines: The pulling of the rezoning also comes at a time when financing for office and lab buildings is much harder to come by.


Business Wire
28 minutes ago
- Business Wire
BioHub Maryland, Powered by the Maryland Tech Council, Partners with Bowie State University On Summer Life Sciences Training for Students
ROCKVILLE, Md.--(BUSINESS WIRE)--In a move to expand pathways into Maryland's life sciences industry, BioHub Maryland, powered by Maryland Tech Council, and Bowie State University, the state's first historically Black College/University, are partnering to give two dozen undergraduates hands-on experience in biopharmaceutical manufacturing this summer. By working with Bowie State University, we're ensuring a more robust pipeline of talent is ready to lead the next generation of biotech breakthroughs—right here in Maryland. The partnership aims to equip students with the technical skills needed to fill in-demand jobs in one of Maryland's most innovative industries. Over four weeks, students from the university's Department of Natural Sciences receive immersive, lab-based training at the BioHub Maryland Training and Education Center in Rockville— an 8,200 square-foot facility replicating real-world biopharma production environments. 'BioHub Maryland doesn't just train students—it launches careers,' said Kelly Schulz, Chief Executive Officer of the Maryland Tech Council. 'By working with Bowie State University, we're ensuring a more robust pipeline of talent is ready to lead the next generation of biotech breakthroughs—right here in Maryland.' Students will learn core biopharma manufacturing skills such as upstream processing, cell culture, and quality control—all of which are essential to the production of vaccines and other treatments. Curricula is designed by the National Institute for Bioprocessing Research and Training (NIBRT), BioHub Maryland's globally-trusted training provider. Upon completion, each student will earn a certificate recognized by life sciences employers. Training takes place at the Rockville-based BioHub Maryland Training and Education Center at Montgomery County, a state-of-the-art facility made possible by Montgomery County and the State of Maryland. The partnership between BioHub Maryland and Bowie State University accelerates Maryland's life sciences leadership. Home to 2,700 life sciences companies and 54,000 life sciences workers, the state is part of the BioHealth Capital Region, recently ranked the #3 biopharma cluster in the U.S. Bowie State's Department of Natural Sciences Chair and Professor, Dr. George Ude, and Associate Professor, Dr. Supriyo Ray, secured this opportunity for their students through a National Institute of Standards & Technology (NIST) grant. About BioHub Maryland BioHub Maryland is accelerating the life sciences industry for companies and career seekers to expand the state's global innovation advantage. A workforce initiative of the Maryland Tech Council, the largest technology and life sciences trade association in the state, BioHub Maryland enables residents of all backgrounds to compete for rewarding careers in life sciences by offering skills training, career resources, and access to job openings. BioHub Maryland also helps life sciences companies at every stage grow by showcasing their career opportunities, training the next generation of life sciences talent, and providing strategic resources for raising capital. Learn more at and follow us on LinkedIn, Instagram, Facebook, and Twitter.


Forbes
42 minutes ago
- Forbes
Will FTSE 100 Energy Giant BP Finally Give Investors Some Joy?
BP logo sits on a totem sign at fuel station in Cambridge, U.K. (Photo: Jason Alden/Bloomberg) © 2020 Bloomberg Finance LP After a good few years of disappointment languishing in the shadows of Big Oil rivals, executive departures, costly renewables forays, rumors of a takeover and an activist investor on its back, BP (LON: BP) has finally signalled to the market and its investors that a change might be on the horizon, backed up an improved quarterly performance. On Tuesday, the energy major revealed better-than-expected results for the second quarter of 2025, with an adjusted net income of $2.4 billion, down 14% year-on-year, but well above market forecasts in the $1.7-$1.9 billion range. The announcement of an improved performance came a day after BP claimed it had made its largest oil and gas discovery in 25 years in the Santos basin, 400 km off Brazil's east coast. It was also accompanied by a pledge from CEO Murray Auchincloss that his company "can and will do better." The Brazilian discovery - said to be as game changing for the company as its Shah Deniz gas field find in the Caspian Sea in 1999 - would likely help as it continues to pull back from renewable energy moves made under Auchincloss' scandal-ridden predecessor Bernard Looney and departing chairman Helge Lund. Since taking over as CEO in 2024, Auchincloss has been steadily reducing BP's renewable energy exposure and investing in oil and gas. The Brazil discovery, coupled with successes in Namibia, Egypt, Mauritania, Senegal, Trinidad & Tobago, and an overt desire to raise both onshore and offshore production in the U.S., are all clear signs of a return to oil and gas basics, ahead of the arrival of incoming chairman Albert Manifold. He is expected to join BP's board next month to fully replace Lund in October. The company is planning on increasing investment in its upstream oil and gas business by around 20% to $10 billion a year through to 2027 in order to 'grow and strengthen' its portfolio. Murray Auchincloss, CEO of BP (Photo: Aaron M. Sprecher/Bloomberg) © 2025 Bloomberg Finance LP "We will conduct a thorough review of our portfolio of businesses to ensure we are maximizing shareholder value moving forward – allocating capital effectively. We are also initiating a further cost review. BP can and will do better for its investors," Auchincloss said, at the release of the latest financials. Can Investors Breathe A Sigh Of Relief? To provide some comfort to patient investors, BP also raised its quarterly dividend by 4% to 8.32 cents a share and will repurchase $750 million in shares before third quarter results, keeping the pace of its buyback steady. Another reset from a reset back February is coming their way, as Auchincloss noted in an analysts' call: "It's time to take stock as Albert joins as a new chair, and work together on this conundrum of lots of lots of great opportunities, but you can only choose so many." The initial reset arrived after February 13 as activist investor Elliott Investment Management revealed it had taken a near-5% stake in BP, and amid persistent rumors of a takeover approach by Shell, which was recently denied by the latter. BP's focus, back then as it is now, is on cost cuts too. The company said it had already achieved $1.7 billion of its $4-$5 billion cost-cutting target for 2023–27. BP's net debt also fell by $1 billion to $26 billion, compared with a target range of $14-$18 billion by 2027. BP's divestment program also appears to be going well too. It has completed $3 billion in divestments towards its $3-$4 billion goal for the end of the current year. It all seems encouraging, and valuation rewards may follow if the market sees the turnaround momentum being maintained. Following Tuesday's uptick, BP's share price was up by 3.3% since the start of the year, down 3.4% on an annualized basis. The intraday gains also dragged BP's 5-year share price gains to around 45%. But by contrast, on a comparable 5-year gains basis on Tuesday, Shell's (LON: SHEL) share price came in 133% higher, Chevron's (NYSE: CVX) 75% ,and ExxonMobil's (LON: XOM) 146%. That shows BP, Auchincloss and Manifold still have a lot of work to do to bridge that gap. But for the first time in years, something feels different. How it all ultimately pans out remains to be seen. Disclaimer: The above commentary is meant to stimulate discussion based on the author's opinion and analysis offered in a personal capacity. It is not solicitation, recommendation or investment advice to trade oil and gas stocks, futures, options or products. Energy and equity markets can be highly volatile and opinions in the sector may change instantaneously and without notice.